Amwill Health

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0U2L01017
  • NSEID:
  • BSEID: 544353
INR
43.06
-1.49 (-3.34%)
BSENSE

Sep 23, 02:18 PM

BSE+NSE Vol: 8400

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Balance Sheet Analysis Highlights
stock-summary

Borrowings

No Borrowings in the last few periods;

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2026 is 7.14% vs -3.45% in Mar 2025

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2026 is -5.00% vs 23.71% in Mar 2025

stock-summary

Investments

No Investments in the last few periods;

stock-summary

Current Assets

YoY Growth in year ended Mar 2026 is 225.48% vs 26.35% in Mar 2025

Compare Balance Sheet Results of Amwill Health
Markets Mojo
Figures in Cr
Standalone - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
20.00
13.88
6.12
44.09%
Share Warrants & Outstandings
Total Reserve
60.57
77.70
-17.13
-22.05%
Shareholder's Funds
80.58
91.57
-10.99
-12.00%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.45
-0.45
-100.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.45
-0.45
-100.00%
Deferred Tax Assets / Liabilities
-0.27
-0.21
-0.06
-28.57%
Other Long Term Liabilities
0.30
0.22
0.08
36.36%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.91
-0.91
-100.00%
Total Non-Current Liabilities
0.03
1.37
-1.34
-97.81%
Current Liabilities
Trade Payables
2.44
21.70
-19.26
-88.76%
Other Current Liabilities
3.35
5.90
-2.55
-43.22%
Short Term Borrowings
0.00
3.73
-3.73
-100.00%
Short Term Provisions
0.00
0.34
-0.34
-100.00%
Total Current Liabilities
5.79
31.67
-25.88
-81.72%
Total Liabilities
86.40
124.61
-38.21
-30.66%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
2.72
124.53
-121.81
-97.82%
Less: Accumulated Depreciation
1.58
87.42
-85.84
-98.19%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
1.14
37.12
-35.98
-96.93%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.20
0.00
0.20
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
2.51
0.00
2.51
0.00%
Long Term Loans & Advances
0.00
1.92
-1.92
-100.00%
Other Non Current Assets
10.74
0.24
10.50
4,375.00%
Total Non-Current Assets
14.60
39.27
-24.67
-62.82%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
0.83
10.60
-9.77
-92.17%
Sundry Debtors
20.90
38.65
-17.75
-45.92%
Cash and Bank
47.37
29.00
18.37
63.34%
Other Current Assets
0.42
0.07
0.35
500.00%
Short Term Loans and Advances
2.28
7.02
-4.74
-67.52%
Total Current Assets
71.80
85.34
-13.54
-15.87%
Net Current Assets (Including Current Investments)
66.01
53.68
12.33
22.97%
Total Current Assets Excluding Current Investments
71.80
85.34
-13.54
-15.87%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
86.40
124.61
-38.21
-30.66%
Contingent Liabilities
0.00
19.88
-19.88
-100.00%
Total Debt
0.00
4.18
-4.18
-100.00%
Book Value per share (adjusted)
40.28
65.99
-25.71
-38.96%
Annual - Borrowings
Borrowings 0.00 Cr
in Mar 2026

Figures in Cr
stock-summary

No Borrowings in the last few periods;

Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.30 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 7.14% vs -3.45% in Mar 2025

Annual - Fixed Assets
Fixed Assets 1.14 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -5.00% vs 23.71% in Mar 2025

Annual - Investments
Investments 2.51 Cr
in Mar 2026

Figures in Cr
stock-summary

No Investments in the last few periods;

Annual - Current Assets
Current Assets 71.80 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 225.48% vs 26.35% in Mar 2025